Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Abstract : Anthracycline extravasation is an uncommon but very serious complication. Very few data are available in the literature concerning the consequences and the management of extravasation of liposomal doxorubicin. This report describes the cases of two patients with liposomal doxorubicin extravasation who developed irritant reaction without vesicant or necrotic lesions. It is concordant with other cases described in the literature and suggests that extravasation of liposomal doxorubicin can be relatively well tolerated. The process applied to extravasations of irritant and non-vesicant agents could be used to manage extravasations of liposomal doxorubicin.
Type de document :
Article dans une revue
Anticancer Research, International Institute of Anticancer Research, 2012, 32 (4), pp.1481-3
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00821491
Contributeur : Philippe Saas <>
Soumis le : vendredi 10 mai 2013 - 14:20:09
Dernière modification le : lundi 9 juillet 2018 - 13:12:02

Identifiants

  • HAL Id : inserm-00821491, version 1
  • PUBMED : 22493389

Collections

Citation

Elsa Curtit, Loïc Chaigneau, Julien Pauchot, Thierry Nguyen, Virginie Nerich, et al.. Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.. Anticancer Research, International Institute of Anticancer Research, 2012, 32 (4), pp.1481-3. 〈inserm-00821491〉

Partager

Métriques

Consultations de la notice

95